Literature DB >> 28751561

Exome sequencing identifies recurrent BCOR alterations and the absence of KLF2, TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small B-cell lymphoma.

Laurent Jallades1,2, Lucile Baseggio1,2, Pierre Sujobert1,2,3, Sarah Huet1,2,3, Kaddour Chabane1,2, Evelyne Callet-Bauchu1,2,3, Aurélie Verney2,3, Sandrine Hayette1,2, Jean-Pierre Desvignes4,5, David Salgado4,5, Nicolas Levy4,5,6, Christophe Béroud4,5,6, Pascale Felman1,2, Françoise Berger2,3,7, Jean-Pierre Magaud1,2,3, Laurent Genestier2, Gilles Salles8,3,9, Alexandra Traverse-Glehen2,3,7.   

Abstract

Splenic diffuse red pulp lymphoma is an indolent small B-cell lymphoma recognized as a provisional entity in the World Health Organization 2008 classification. Its precise relationship to other related splenic B-cell lymphomas with frequent leukemic involvement or other lymphoproliferative disorders remains undetermined. We performed whole-exome sequencing to explore the genetic landscape of ten cases of splenic diffuse red pulp lymphoma using paired tumor and normal samples. A selection of 109 somatic mutations was then evaluated in a cohort including 42 samples of splenic diffuse red pulp lymphoma and compared to those identified in 46 samples of splenic marginal zone lymphoma and eight samples of hairy-cell leukemia. Recurrent mutations or losses in BCOR (the gene encoding the BCL6 corepressor) - frameshift (n=3), nonsense (n=2), splicing site (n=1), and copy number loss (n=4) - were identified in 10/42 samples of splenic diffuse red pulp lymphoma (24%), whereas only one frameshift mutation was identified in 46 cases of splenic marginal zone lymphoma (2%). Inversely, KLF2, TNFAIP3 and MYD88, common mutations in splenic marginal zone lymphoma, were rare (one KLF2 mutant in 42 samples; 2%) or absent (TNFAIP3 and MYD88) in splenic diffuse red pulp lymphoma. These findings define an original genetic profile of splenic diffuse red pulp lymphoma and suggest that the mechanisms of pathogenesis of this lymphoma are distinct from those of splenic marginal zone lymphoma and hairy-cell leukemia. Copyright
© 2017 Ferrata Storti Foundation.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28751561      PMCID: PMC5622860          DOI: 10.3324/haematol.2016.160192

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  42 in total

1.  Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype.

Authors:  Vera Grossmann; Enrico Tiacci; Antony B Holmes; Alexander Kohlmann; Maria Paola Martelli; Wolfgang Kern; Ariele Spanhol-Rosseto; Hans-Ulrich Klein; Martin Dugas; Sonja Schindela; Vladimir Trifonov; Susanne Schnittger; Claudia Haferlach; Renato Bassan; Victoria A Wells; Orietta Spinelli; Joseph Chan; Roberta Rossi; Stefano Baldoni; Luca De Carolis; Katharina Goetze; Hubert Serve; Rudolf Peceny; Karl-Anton Kreuzer; Daniel Oruzio; Giorgina Specchia; Francesco Di Raimondo; Francesco Fabbiano; Marco Sborgia; Arcangelo Liso; Laurent Farinelli; Alessandro Rambaldi; Laura Pasqualucci; Raul Rabadan; Torsten Haferlach; Brunangelo Falini
Journal:  Blood       Date:  2011-10-19       Impact factor: 22.113

2.  CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.

Authors:  Lucile Baseggio; Alexandra Traverse-Glehen; Florence Petinataud; Evelyne Callet-Bauchu; Françoise Berger; Martine Ffrench; Chantal Marie Couris; Catherine Thieblemont; Dominique Morel; Bertrand Coiffier; Gilles Salles; Pascale Felman
Journal:  Haematologica       Date:  2009-12-16       Impact factor: 9.941

3.  Bone marrow histopathology in the diagnostic evaluation of splenic marginal-zone and splenic diffuse red pulp small B-cell lymphoma: a reliable substitute for spleen histopathology?

Authors:  Maurilio Ponzoni; George Kanellis; Evi Pouliou; Panagiotis Baliakas; Lydia Scarfò; Andrés J M Ferreri; Claudio Doglioni; Vasilis Bikos; Antonis Dagklis; Achilles Anagnostopoulos; Paolo Ghia; Kostas Stamatopoulos; Theodora Papadaki
Journal:  Am J Surg Pathol       Date:  2012-11       Impact factor: 6.394

4.  BRAF mutations in hairy-cell leukemia.

Authors:  Enrico Tiacci; Vladimir Trifonov; Gianluca Schiavoni; Antony Holmes; Wolfgang Kern; Maria Paola Martelli; Alessandra Pucciarini; Barbara Bigerna; Roberta Pacini; Victoria A Wells; Paolo Sportoletti; Valentina Pettirossi; Roberta Mannucci; Oliver Elliott; Arcangelo Liso; Achille Ambrosetti; Alessandro Pulsoni; Francesco Forconi; Livio Trentin; Gianpietro Semenzato; Giorgio Inghirami; Monia Capponi; Francesco Di Raimondo; Caterina Patti; Luca Arcaini; Pellegrino Musto; Stefano Pileri; Claudia Haferlach; Susanne Schnittger; Giovanni Pizzolo; Robin Foà; Laurent Farinelli; Torsten Haferlach; Laura Pasqualucci; Raul Rabadan; Brunangelo Falini
Journal:  N Engl J Med       Date:  2011-06-11       Impact factor: 91.245

Review 5.  The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Authors:  Steven H Swerdlow; Elias Campo; Stefano A Pileri; Nancy Lee Harris; Harald Stein; Reiner Siebert; Ranjana Advani; Michele Ghielmini; Gilles A Salles; Andrew D Zelenetz; Elaine S Jaffe
Journal:  Blood       Date:  2016-03-15       Impact factor: 22.113

6.  KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype.

Authors:  A Clipson; M Wang; L de Leval; M Ashton-Key; A Wotherspoon; G Vassiliou; N Bolli; C Grove; S Moody; L Escudero-Ibarz; G Gundem; K Brugger; X Xue; E Mi; A Bench; M Scott; H Liu; G Follows; E F Robles; J A Martinez-Climent; D Oscier; A J Watkins; M-Q Du
Journal:  Leukemia       Date:  2014-11-27       Impact factor: 11.528

Review 7.  Extranodal and splenic small B-cell lymphoma.

Authors:  Andrew C Wotherspoon
Journal:  Mod Pathol       Date:  2013-01       Impact factor: 7.842

8.  The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development.

Authors:  Davide Rossi; Vladimir Trifonov; Marco Fangazio; Alessio Bruscaggin; Silvia Rasi; Valeria Spina; Sara Monti; Tiziana Vaisitti; Francesca Arruga; Rosella Famà; Carmela Ciardullo; Mariangela Greco; Stefania Cresta; Daniela Piranda; Antony Holmes; Giulia Fabbri; Monica Messina; Andrea Rinaldi; Jiguang Wang; Claudio Agostinelli; Pier Paolo Piccaluga; Marco Lucioni; Fabrizio Tabbò; Roberto Serra; Silvia Franceschetti; Clara Deambrogi; Giulia Daniele; Valter Gattei; Roberto Marasca; Fabio Facchetti; Luca Arcaini; Giorgio Inghirami; Francesco Bertoni; Stefano A Pileri; Silvia Deaglio; Robin Foà; Riccardo Dalla-Favera; Laura Pasqualucci; Raul Rabadan; Gianluca Gaidano
Journal:  J Exp Med       Date:  2012-08-13       Impact factor: 14.307

9.  Comparison of two next-generation sequencing kits for diagnosis of epileptic disorders with a user-friendly tool for displaying gene coverage, DeCovA.

Authors:  Sarra Dimassi; Thomas Simonet; Audrey Labalme; Nadia Boutry-Kryza; Amandine Campan-Fournier; Raphaelle Lamy; Claire Bardel; Mad-Hélénie Elsensohn; Florence Roucher-Boulez; Nicolas Chatron; Audrey Putoux; Julitta de Bellescize; Dorothée Ville; Laurent Schaeffer; Pascal Roy; Soumaya Mougou-Zerelli; Ali Saad; Alain Calender; Damien Sanlaville; Gaetan Lesca
Journal:  Appl Transl Genom       Date:  2015-10-17

10.  Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type.

Authors:  Seungbok Lee; Ha Young Park; So Young Kang; Seok Jin Kim; Jinha Hwang; Seungho Lee; Soo Heon Kwak; Kyong Soo Park; Hae Yong Yoo; Won Seog Kim; Jong-Il Kim; Young Hyeh Ko
Journal:  Oncotarget       Date:  2015-07-10
View more
  22 in total

1.  CBL-MZ is not a single biological entity: evidence from genomic analysis and prolonged clinical follow-up.

Authors:  Helen Parker; Neil Robert McIver-Brown; Zadie A Davis; Marina Parry; Matthew J J Rose-Zerilli; Aliki Xochelli; Jane Gibson; Renata Walewska; Jonathan C Strefford; David G Oscier
Journal:  Blood Adv       Date:  2018-05-22

2.  Mcm2 hypomorph leads to acute leukemia or hematopoietic stem cell failure, dependent on genetic context.

Authors:  Toshihiro Matsukawa; Mianmian Yin; Timour Baslan; Yang Jo Chung; Dengchao Cao; Ryan Bertoli; Yuelin J Zhu; Robert L Walker; Amy Freeland; Erik Knudsen; Scott W Lowe; Paul S Meltzer; Peter D Aplan
Journal:  FASEB J       Date:  2022-09       Impact factor: 5.834

Review 3.  Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances.

Authors:  Jérôme Paillassa; Elsa Maitre; Xavier Troussard
Journal:  Curr Oncol Rep       Date:  2022-04-11       Impact factor: 5.945

4.  A Case Series of BCOR Sarcomas With a New Splice Variant of BCOR/CCNB3 Fusion Gene.

Authors:  Anastasios Kyriazoglou; Natalia Tourkantoni; Michalis Liontos; Flora Zagouri; Louisa Mahaira; Alexandra Papakosta; Dimitra Michali; Amalia Patereli; Kalliopi Stefanaki; Vasiliki Tzotzola; Evangelia Skoura; Margarita Baka; Sofia Polychronopoulou; Antonis Kattamis; Efthymios Dimitriadis
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

5.  Mutational profile and EBV strains of extranodal NK/T-cell lymphoma, nasal type in Latin America.

Authors:  Ivonne A Montes-Mojarro; Bo-Jung Chen; Ana F Ramirez-Ibarguen; Carmen M Quezada-Fiallos; Wendy B Pérez-Báez; Daniela Dueñas; Sandro Casavilca-Zambrano; Marcela Ortiz-Mayor; Erica Rojas-Bilbao; Hernan García-Rivello; Maria F Metrebian; Marina Narbaitz; Carlos Barrionuevo; Carmen Lome-Maldonado; Irina Bonzheim; Falko Fend; Julia Steinhilber; Leticia Quintanilla-Martinez
Journal:  Mod Pathol       Date:  2019-12-10       Impact factor: 7.842

Review 6.  MAP-Kinase-Driven Hematopoietic Neoplasms: A Decade of Progress in the Molecular Age.

Authors:  Rikhia Chakraborty; Omar Abdel-Wahab; Benjamin H Durham
Journal:  Cold Spring Harb Perspect Med       Date:  2021-05-03       Impact factor: 6.915

Review 7.  BCOR gene alterations in hematologic diseases.

Authors:  Paolo Sportoletti; Daniele Sorcini; Brunangelo Falini
Journal:  Blood       Date:  2021-12-16       Impact factor: 22.113

8.  Toll-like receptor expression and function differ between splenic marginal zone B cell lymphoma and splenic diffuse red pulp B cell lymphoma.

Authors:  Aurélie Verney; Alexandra Traverse-Glehen; Evelyne Callet-Bauchu; Laurent Jallades; Jean-Pierre Magaud; Gilles Salles; Laurent Genestier; Lucile Baseggio
Journal:  Oncotarget       Date:  2018-05-04

9.  Hairy cell leukemia 2018: Update on diagnosis, risk-stratification, and treatment.

Authors:  Xavier Troussard; Edouard Cornet
Journal:  Am J Hematol       Date:  2017-12       Impact factor: 10.047

10.  VarAFT: a variant annotation and filtration system for human next generation sequencing data.

Authors:  Jean-Pierre Desvignes; Marc Bartoli; Valérie Delague; Martin Krahn; Morgane Miltgen; Christophe Béroud; David Salgado
Journal:  Nucleic Acids Res       Date:  2018-07-02       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.